157 related articles for article (PubMed ID: 9799694)
21. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression.
Chiappetta G; Botti G; Monaco M; Pasquinelli R; Pentimalli F; Di Bonito M; D'Aiuto G; Fedele M; Iuliano R; Palmieri EA; Pierantoni GM; Giancotti V; Fusco A
Clin Cancer Res; 2004 Nov; 10(22):7637-44. PubMed ID: 15569996
[TBL] [Abstract][Full Text] [Related]
22. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
23. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
24. Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy.
Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Humpfer E; Spraul M; Carreira IM; Melo JB; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2010 Jan; 9(1):319-32. PubMed ID: 19908917
[TBL] [Abstract][Full Text] [Related]
25. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
26. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
27. Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy.
Duarte IF; Stanley EG; Holmes E; Lindon JC; Gil AM; Tang H; Ferdinand R; McKee CG; Nicholson JK; Vilca-Melendez H; Heaton N; Murphy GM
Anal Chem; 2005 Sep; 77(17):5570-8. PubMed ID: 16131067
[TBL] [Abstract][Full Text] [Related]
28. [FTIR spectroscopic characterization of freshly removed breast cancer tissues].
Zhou S; Xu Z; Ling XF; Li QB; Xu YZ; Zhang L; Zhao HM; Wang LX; Hou KY; Zhou XS; Wu JG
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):512-4. PubMed ID: 17147115
[TBL] [Abstract][Full Text] [Related]
29. Contrast-enhanced dynamic MR imaging parameters and histological types of invasive ductal carcinoma of breast.
Takeda Y; Yoshikawa K
Biomed Pharmacother; 2005 Apr; 59(3):115-21. PubMed ID: 15795104
[TBL] [Abstract][Full Text] [Related]
30. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra.
Tugnoli V; Schenetti L; Mucci A; Parenti F; Cagnoli R; Righi V; Trinchero A; Nocetti L; Toraci C; Mavilla L; Trentini G; Zunarelli E; Tosi MR
Int J Mol Med; 2006 Nov; 18(5):859-69. PubMed ID: 17016616
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
33. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Zhao TT; Li JG; Li YM
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?
Pfisterer WK; Hendricks WP; Scheck AC; Nieman RA; Birkner TH; Krampla WW; Preul MC
Neurosurgery; 2007 Nov; 61(5):1048-59; discussion 1060-1. PubMed ID: 18091281
[TBL] [Abstract][Full Text] [Related]
35. Fine-needle aspiration cytology of breast carcinoma with endocrine differentiation.
Tse GM; Ma TK
Cancer; 2000 Oct; 90(5):286-91. PubMed ID: 11038425
[TBL] [Abstract][Full Text] [Related]
36. Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.
Zakian KL; Shukla-Dave A; Meyers P; Gorlick R; Healey J; Thaler HT; Huvos AG; Panicek DM; Koutcher JA
Cancer Res; 2003 Dec; 63(24):9042-7. PubMed ID: 14695223
[TBL] [Abstract][Full Text] [Related]
37. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.
Yang Y; Li C; Nie X; Feng X; Chen W; Yue Y; Tang H; Deng F
J Proteome Res; 2007 Jul; 6(7):2605-14. PubMed ID: 17564425
[TBL] [Abstract][Full Text] [Related]
38. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
39. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
40. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
